---
schema_version: "secwatch.filing_event.v1"
accession: "0001100682-25-000014"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2025-02-21T23:59:59+00:00"
generated_at: "2026-05-26T06:46:50.118008+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CEO Foster buys $1M in CRL stock; COO Girshick buys $250K

## Summary
- CEO James Foster purchased 6,075 shares at avg $165.01 (~$1M); COO Girshick purchased 1,514 shares at avg $164.63 (~$250K) on Feb 20, 2025.
- Both terminated existing Rule 10b5-1 trading plans on Feb 19 to allow purchases without violating Section 16 short-swing profit rules.
- Foster's plan allowed up to 129,721 shares; he sold 25,000 shares under it in Aug 2024. Girshick's plan allowed up to 22,362 shares; no sales occurred.
- Executives cited confidence in strategic direction and long-term growth prospects as reason for open-market purchases.

## SEC filing metadata
- accession: 0001100682-25-000014
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2025-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000110068225000014/0001100682-25-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000110068225000014/crl-20250220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001100682-25-000014
- JSON: https://secwatch.observer/filing/0001100682-25-000014.json
- Plain text: https://secwatch.observer/filing/0001100682-25-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.